Evidence map›Paper›PMID 28704441›Full record

ArticlePloS one2017

A comparison of sex steroid concentration levels in the vitreous and serum of patients with vitreoretinal diseases.

Yuko Nishikawa, Seita Morishita, Taeko Horie, Masanori Fukumoto, Takaki Sato, Teruyo Kida, Hidehiro Oku, Jun Sugasawa, Tsunehiko Ikeda, Kimitoshi Nakamura

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yuko NishikawaDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Seita MorishitaDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Taeko HorieDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Masanori FukumotoDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Takaki SatoDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Teruyo KidaDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Hidehiro OkuDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Jun SugasawaDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.
Tsunehiko IkedaDepartment of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan.ORCID http://orcid.org/0000-0001-5654-0282
Kimitoshi NakamuraNakamura Eye Clinic, Matsumoto-City, Nagano, Japan.
Osaka Medical and Pharmaceutical University · JPThe Nakamura Hajime Eastern Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to compare steroid hormone concentration levels in the vitreous and serum of vitreoretinal disease patients to elucidate the possibility of neurosteroid production in the retina. Serum and vitreous samples were collected from vitrectomy patients, and estradiol (E2) and testosterone (T) concentrations were measured using electro-chemiluminescence immunoassay. We measured E2 in epiretinal membrane (ERM, n = 14), macular hole (MH, n = 18), proliferative diabetic retinopathy (PDR, n = 20), and retinal detachment (RD, n = 19) cases, and T in ERM (n = 14), MH (n = 17), PDR (n = 13), and RD (n = 17) cases. No statistically significant age differences existed among the groups. Mean respective E2 concentrations (pg/ml) in the male/female vitreous were ERM: 6.67±4.04/18.82±7.10, MH: 10.3±7.02/17.00±4.8, PDR: 4.2±3.05/15.83±3.46, and RD: 10.00±4.58/16.06±4.57, while those in serum were ERM: 31.67±5.51/5.82±1.08, MH: 21.00±8.89/7.53±3.2, PDR: 29.20±7.07/12.75±10.62, and RD: 24.33±6.51/7.5±4.42. E2 concentrations were significantly higher (P<0.001) in the male serum than vitreous, yet significantly higher in the female vitreous than serum. Mean respective T concentrations (ng/ml) in the male/female vitreous were ERM: 0.15±0.03/0.15±0.01, MH: 0.15±0.01/0.15±0.01, PDR: 0.15±0.03/0.16±0.12, and RD: 0.14±0.01/0.17±0.08, while those in serum were ERM: 4.54±1.46/0.16±0.01, MH: 8.04±2.29/0.16±0.10, PDR: 5.14±1.54/0.22±0.11, and RD: 3.24±0.75/0.17±0.10. T concentrations were high in the male serum, yet extremely low in the male and female vitreous and female serum. High concentrations of E2 were found in the vitreous, and women, in particular, exhibited significantly higher concentrations in the vitreous than in the serum. This finding suggests the possibility that in vitreoretinal disease cases, the synthesis of E2 is increased locally only in female eyes.

Indexed as

AdultAgedAged, 80 and overDiabetic RetinopathyEpiretinal MembraneFemaleGonadal Steroid HormonesHumansMaleMiddle AgedRetinal DetachmentRetinal PerforationsSex CharacteristicsVitrectomyVitreous BodyGonadal Steroid Hormones

Identifiers

PMID28704441
PMCPMC5509246
OpenAlexW2734752533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.